Edition:
United States

Shire PLC (SHP.L)

SHP.L on London Stock Exchange

4,448.50GBp
7:52am EDT
Change (% chg)

5.50 (+0.12%)
Prev Close
4,443.00
Open
4,443.00
Day's High
4,450.00
Day's Low
4,431.00
Volume
329,200
Avg. Vol
3,190,876
52-wk High
4,514.50
52-wk Low
2,940.50

Chart for

About

Shire plc is a biotech company focused on serving people with rare diseases and other specialized conditions. The Company's segment is engaged in research, development, licensing, manufacturing, marketing, distribution and sale of specialist medicines. It focuses its development resources on projects in various therapeutic areas... (more)

Overall

Beta: 1.42
Market Cap(Mil.): £40,397.06
Shares Outstanding(Mil.): 914.44
Dividend: 4.26
Yield (%): --

Financials

  SHP.L Industry Sector
P/E (TTM): 21.15 28.11 30.17
EPS (TTM): 2.10 -- --
ROI: 4.06 12.95 12.67
ROE: 7.16 14.96 14.86

Shire profit edges higher ahead of Takeda sale

LONDON Shire , the London-listed pharmaceutical group being bought by Japan's Takeda , reported a 4 percent rise in second-quarter earnings as revenue rose 5 percent to $3.92 billion, just ahead of market expectations.

Jul 31 2018

UPDATE 1-Shire profit edges higher ahead of Takeda sale

LONDON, July 31 Shire, the London-listed pharmaceutical group being bought by Japan's Takeda, reported a 4 percent rise in second-quarter earnings as revenue rose 5 percent to $3.92 billion, just ahead of market expectations.

Jul 31 2018

Shire posts 4 pct rise in Q2 earnings ahead of sale to Takeda

LONDON, July 31 Shire, the London-listed pharmaceutical group being bought by Japan's Takeda, reported a 4 percent rise in second-quarter earnings as revenue rose 5 percent to $3.92 billion, just ahead of market expectations.

Jul 31 2018

Takeda operating profit halves, looks to asset sales to shore up finances

TOKYO Japan's Takeda Pharmaceutical Co Ltd on Tuesday reported that its operating profit halved from the year-ago quarter, when the drugmaker had booked gains from asset sales.

Jul 31 2018

UPDATE 2-Takeda operating profit halves, looks to asset sales to shore up finances

* Shire-related costs helped push debt ratio higher (Adds details from news conference)

Jul 31 2018

Buy yen in crisis? Not this year

LONDON/TOKYO The trade is familiar to investors worldwide: in times of turmoil, rush for cover by buying the Japanese yen.

Jul 24 2018

Generic drugmaker owes Shire $1.5 million in fees after sanction

A federal judge on Wednesday awarded Adderall XR maker Shire PLC more than $1.5 million to cover attorneys' fees and expenses it incurred dealing with a generic drug company's "litigation misconduct" in the course of a patent infringement lawsuit.

Jul 11 2018

Japan's Takeda gains U.S. approval for $62 billion Shire buy

TOKYO Takeda Pharmaceutical Co Ltd on Tuesday said it has received U.S. approval for its $62 billion acquisition of London-listed Shire Plc, taking the Japanese firm one step closer to its goal of becoming a global top 10 drugmaker.

Jul 10 2018

UPDATE 2-Japan's Takeda gains US approval for $62 bln Shire buy

* Also needs approval from Takeda, Shire shareholders (Adds share movement)

Jul 10 2018

Takeda gets key U.S. regulatory approval to buy Shire

TOKYO, July 10 Japan's Takeda Pharmaceutical Co Ltd said on Tuesday it received a key U.S. regulatory approval for its $62 billion deal to buy London-listed Shire Plc .

Jul 10 2018

Earnings vs. Estimates